Attorney Profile
Steven M. Lieberman

Steven M. Lieberman

Steven Lieberman

Rothwell, Figg, Ernst & Manbeck, P.C.
1425 K Street, Northwest, Suite 800
Washington, DC 20005
Contact Contact Steven M. Lieberman
T: 202-783-6040
F: 202-783-6031

Visit: www.rothwellfigg.com
Practice areas: Intellectual Property Litigation (50%), Intellectual Property (30%), First Amendment/Media/Advertising (20%)
Law School: Columbia Law School

Profile

For the past 18 years, Mr. Lieberman has specialized in patent litigation in the pharmaceutical field, handling more than 30 such matters, including serving as lead counsel in In re Buspirone, in which Bristol Myers paid $535 million to settle the antitrust counterclaims brought by Mr. Lieberman’s client and others. Mr. Lieberman has also handled a wide variety of patent cases outside the pharmaceutical area, representing such clients as The New York Times, Dow Jones, Disney, ITG, and LGE. B.A. degree, Princeton University, summa cum laude; J.D. degree, Columbia University Law School; law clerk, Judge Edmund Palmieri (S.D.N.Y.).

Selected to:

Washington, D.C. Super Lawyers 2009
Washington, D.C. Super Lawyers 2008
Washington, D.C. Super Lawyers 2007

About Steven Lieberman

Admitted: 1985, Washington D.C.

Professional Webpage: www.rothwellfigg.com/attorney_Lieberman.php

Honors and Awards: Selected by Law & Politics in 2007 as a Washington, D.C. Super Lawyer in the field of intellectual property litigation.  Honored in 2006 by Ohev Sholom - The National Synagogue and in 2007 by Yeshivat Chovevei Torah for his work on behalf of those organizations.
Bar/Professional Activity: Past President of the Giles S. Rich American Inn of Court, the D.C. Inn devoted to the practice of intellectual property law. Past Chairman of the Defamation and New Technologies Subcommittee of the Committee on Media Law of the New York State Bar Association.  Past Chairman of the Media Law Resource Center Cyberspace Committee. Member of Editorial Advisory Board for BNA's Pharmaceutical Law & Industry Report.
Pro bono/Community Service: Serves on the boards of a number of non-profit organizations including the Beth Sholom Congregation and Talmud Torah, Yeshivat Chovevei Torah, the Association for Safe International Road Travel, and the Charles E. Smith Jewish Day School (2000-2006).
Scholarly Lectures and Writings: Edited two collections of articles on Internet defamation issues for the New York State Bar Association and the MLRC. Commentator on TV/radio on First Amendment issues. Guest Speaker, Food and Drug Law Institute ("FDLI") Enforcement and Litigation Issues in Drug and Medical Device Law: Trouble in Court and How to Stay Out of It by FDLI (2002). Guest Lecturer, Institute for International Research Conference on Generic Drugs (2002); Breakout Session Leader, NAA/NAB/LDRC Libel Conference (Cyberlaw) (1997, 1999, 2002). Invited Speaker, Georgetown Law School, Hatch-Waxman Act (2002); Invited Speaker, Syracuse University College of Law, Patent Policy in the Pharmaceutical Industry (2003). Invited Speaker, FDLI, FDA's New Rule on Patent Listing Requirements and 30-Month Stays (2003). Guest Speaker, Global Generics Strategy Summit: The Battle for "Authorized Generics": Is There a Future? (2007); and Invited Speaker for the IP Organizing Subcommittee of the Maryland State Bar Association: A Trademark as a Sponsored Link: Is it an Actionable "Trademark Use" and is it Infringement? (2007).
Verdicts and Settlements: Mr. Lieberman's representation of Mylan in its patent and antitrust actions against Bristol-Myers Squibb arising from Bristol's improper listing of a buspirone metabolite patent in the Orange Book recently resulted in Bristol paying $535 million to settle antitrust claims brought against it by Mylan, 29 state Attorneys General, and private class action plaintiffs. Mr. Lieberman recently obtained a judgment of willful infringement for an e-commerce client that had sued a competitor for copying several of its online advertisements. In addition to finding willful infringement following a bench trial, the Court awarded Mr. Lieberman's client both statutory damages and more than $250,000 in attorneys' fees and costs.Mr. Lieberman represented Rabbi Avi Weiss in a two week jury trial in the District of Columbia against Howard University arising out of Howard's failure to protect Rabbi Weiss' right to protest speeches by of Khalid Abdul Mohammed at Howard University's campus, obtaining a jury verdict and judgment for Rabbi Weiss.
Representative Clients: The New York Times Company; Dow Jones; Disney; AstraZeneca; Mylan Pharmaceuticals; ITG, Inc.; Northrop Grumman, McGraw-Hill.
Other Outstanding Achievements: Co-author, District of Columbia section of the Media Law Resource Center's annual 50-State Survey of Media Privacy and Related Law (1993-2007 editions).
Map Location

What is Super Lawyers
Super Lawyers Magazine

Super Lawyers magazine names attorneys in each state who received the highest point totals, as chosen by their peers and through the independent research of Law & Politics. Rising Stars names the state's top up-and-coming attorneys.

Super Lawyers magazine is published in all 50 states and reaches more than 13 million readers.

Read more…

Testimonials

"The Profile has been a great resource for client referrals as well as lateral hires. It enhances our name recognition and literally provides a snapshot of our personnel, expertise and credentials. Thank you, Super Lawyers!"
Greg Rubin, Chairman
Rubin, Fortunato & Harbison P.C.
Paoli, Pennsylvania

“Dollar for dollar my Standard Profile advertisement in Super Lawyers provided more positive feedback than any other marketing I’ve done in the past 20 years. Super Lawyers is a tremendous way to raise visibility, build credibility, and best of all, reaffirm the relationships I have worked so hard to establish.”
Theodore J. Fournaris
Fournaris & Sanet PA
Coral Gables, Florida

Read more ...